Maravai LifeSciences Holdings, Inc.

NasdaqGS:MRVI 株式レポート

時価総額:US$1.2b

Maravai LifeSciences Holdings マネジメント

マネジメント 基準チェック /44

Maravai LifeSciences Holdingsの CEO はTrey Martinで、 Jul2023年に任命され、 の在任期間は 1.33年です。 の年間総報酬は$ 2.30Mで、 32.6%給与と67.4%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の0.11%を直接所有しており、その価値は$ 1.33M 。経営陣と取締役会の平均在任期間はそれぞれ2.4年と4年です。

主要情報

Trey Martin

最高経営責任者

US$2.3m

報酬総額

CEO給与比率32.6%
CEO在任期間1.3yrs
CEOの所有権0.1%
経営陣の平均在職期間2.4yrs
取締役会の平均在任期間4yrs

経営陣の近況

Recent updates

Slammed 37% Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Screens Well Here But There Might Be A Catch

Nov 11
Slammed 37% Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Screens Well Here But There Might Be A Catch

Does Maravai LifeSciences Holdings (NASDAQ:MRVI) Have A Healthy Balance Sheet?

Oct 15
Does Maravai LifeSciences Holdings (NASDAQ:MRVI) Have A Healthy Balance Sheet?

Maravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) 29% Jump Shows Its Popularity With Investors

Jul 18
Maravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) 29% Jump Shows Its Popularity With Investors

Does Maravai LifeSciences Holdings (NASDAQ:MRVI) Have A Healthy Balance Sheet?

Jul 15
Does Maravai LifeSciences Holdings (NASDAQ:MRVI) Have A Healthy Balance Sheet?

Maravai: Embedded Expectations Remain Too High Considering Economic Calculus

Jul 12

RGA Investment Advisors - Maravai: Two Elite Assets With Other-Worldly Margins Wrapped In One

Jun 12

Revenues Tell The Story For Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) As Its Stock Soars 25%

May 14
Revenues Tell The Story For Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) As Its Stock Soars 25%

An Intrinsic Calculation For Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Suggests It's 23% Undervalued

Apr 07
An Intrinsic Calculation For Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Suggests It's 23% Undervalued

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Stocks Shoot Up 28% But Its P/S Still Looks Reasonable

Feb 28
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Stocks Shoot Up 28% But Its P/S Still Looks Reasonable

Revenues Working Against Maravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) Share Price

Dec 19
Revenues Working Against Maravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) Share Price

Need To Know: Analysts Just Made A Substantial Cut To Their Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Estimates

Aug 14
Need To Know: Analysts Just Made A Substantial Cut To Their Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Estimates

Are Investors Undervaluing Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) By 27%?

Feb 28
Are Investors Undervaluing Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) By 27%?

Is Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Expensive For A Reason? A Look At Its Intrinsic Value

Nov 01
Is Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Expensive For A Reason? A Look At Its Intrinsic Value

Maravai Lifesciences temporarily reinstates Carl Hull as CEO

Oct 19

Maravai LifeSciences appoints former Danaher executive as CEO

Oct 03

Maravai LifeSciences Holdings GAAP EPS of $0.53 beats by $0.15, revenue of $242.73M beats by $9.51M

Aug 04

Estimating The Intrinsic Value Of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)

Jun 27
Estimating The Intrinsic Value Of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)

Maravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) Intrinsic Value Is Potentially 25% Below Its Share Price

Mar 29
Maravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) Intrinsic Value Is Potentially 25% Below Its Share Price

CEO報酬分析

Maravai LifeSciences Holdings の収益と比較して、Trey Martin の報酬はどのように変化したか?
日付総報酬給与会社業績
Sep 30 2024n/an/a

-US$225m

Jun 30 2024n/an/a

-US$132m

Mar 31 2024n/an/a

-US$131m

Dec 31 2023US$2mUS$750k

-US$119m

Sep 30 2023n/an/a

US$25m

Jun 30 2023n/an/a

US$75m

Mar 31 2023n/an/a

US$153m

Dec 31 2022US$15mUS$660k

US$220m

報酬と市場: Treyの 総報酬 ($USD 2.30M ) は、 US市場 ($USD 5.38M ) の同様の規模の企業の平均を下回っています。

報酬と収益: Treyの報酬は、過去 1 年間の会社の業績と一致しています。


CEO(最高経営責任者

Trey Martin (49 yo)

1.3yrs

在職期間

US$2,301,864

報酬

Mr. William E. Martin, III, also known as Trey, is Director of Maravai LifeSciences Holdings, Inc. from July 31, 2024. He was President of Biologics Safety Testing of Maravai LifeSciences Holdings, Inc. si...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Carl Hull
Co-Founder & Executive Chairman4yrsUS$5.22m0.19%
$ 2.4m
William Martin
CEO & Director1.3yrsUS$2.30m0.11%
$ 1.3m
Kevin Herde
Executive VP & CFO7.5yrsUS$2.79m0.022%
$ 270.2k
Peter Leddy
Executive VP & Chief Administrative Officer2.4yrsUS$2.83m0.039%
$ 480.5k
Christine Dolan
Executive VP & GM of Cygnus Technologies7.1yrsUS$2.26m0.020%
$ 239.3k
Andrew Burch
President of Nucleic Acid Production1.7yrsUS$2.99m0.024%
$ 290.1k
Debra Hart
Senior Director of Investor Relationsno dataデータなしデータなし
Kurt Oreshack
Executive VP4yrsUS$701.40k0.018%
$ 222.6k
Rebecca Buzzeo
Executive VP & Chief Commercial Officer1.8yrsデータなし0.014%
$ 168.8k
Kate Broderick
Chief Innovation Officer1.8yrsデータなしデータなし

2.4yrs

平均在職期間

55yo

平均年齢

経験豊富な経営陣: MRVIの経営陣は 経験豊富 であると考えられます ( 2.4年の平均在職年数)。


取締役

名称ポジション在職期間報酬所有権
Carl Hull
Co-Founder & Executive Chairman4yrsUS$5.22m0.19%
$ 2.4m
William Martin
CEO & Directorless than a yearUS$2.30m0.11%
$ 1.3m
John DeFord
Independent Director1.3yrsUS$435.03k0.049%
$ 601.0k
Constantine Mihas
Non-Independent Director4yrsUS$370.48k0.0030%
$ 36.6k
Sean Cunningham
Non-Independent Director4yrsUS$367.98k0.0030%
$ 36.6k
Gregory Lucier
Independent Director4yrsUS$360.48k0.022%
$ 267.0k
Susannah Gray
Independent Director4yrsUS$395.48k0.025%
$ 310.0k
Benjamin Daverman
Non-Independent Director4yrsUS$360.48k0.0030%
$ 36.6k
Luke Marker
Non-Independent Director4yrsUS$360.48k0.0030%
$ 36.6k
Murali Prahalad
Independent Director4yrsUS$367.98k0.015%
$ 178.7k
Jessica Hopfield
Independent Director4yrsUS$387.98k0.047%
$ 567.5k

4.0yrs

平均在職期間

59yo

平均年齢

経験豊富なボード: MRVIの 取締役会経験豊富 であると考えられます ( 4年の平均在任期間)。